Interviews on biotechnology - Labiotech.eu

Home Interview Page 9

Latest Posts

DNA quantification Stilla Technologies

Interview 13 Dec 2018

Making DNA Quantification More Precise Than Ever

Technology advances are taking DNA quantification to a whole new level of precision by making it possible to identify single molecules in a sample. Philip talked to Rémi Dangla, CEO and co-founder of Stilla Technologies, to discuss advances and challenges in the field. Founded in 2013, Stilla Technologies is a French company that makes and […]

December 13, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

cytera cell culture automation

Interview 5 Dec 2018

How Automation Will Enable the Age of Cell Therapy

Scientists in biotech and pharma spend more and more of their valuable time culturing cells manually. Automated cell culture is still not standard in the early research stages, and many believe that needs to change. Philip talked to Ali Afshar, co-founder of Cytera Cellworks to discuss how the main obstacles to bringing automation to cell […]

December 5, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

orphazyme rare disease lysosome DNA

Interview 28 Nov 2018

Navigating the Rare Disease Space: Insights from a Danish CEO

Developing drugs for rare diseases is a tough nut for biotech companies to crack. Labiotech’s Helen Albert interviewed the CEO of the Danish company Orphazyme, Anders Hinsby, at the recent BIO-Europe conference in Copenhagen, who told her about the appeals and challenges of making it in the rare disease space. Traditionally, the low number of […]

November 28, 2018 - 5 minutesmins - By Jonathan Smith

denmark biotech industry

Interview 20 Nov 2018

Why Denmark Is a Strong Player in Europe’s Biotech Industry

Denmark is a rapidly growing hotspot for biotech. During the BIO-Europe conference in Copenhagen, I talked to Mette Kirstine Agger, Managing Partner at the life sciences investor Lundbeckfonden Ventures, to learn more about how the industry is evolving in Europe and Denmark. The US has traditionally been the leader in biotech, but that seems to […]

November 20, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Claus Crone Fuglsang Novozymes Industrial Biotechnology Bioeconomy

Interview 8 Nov 2018

How Industrial Biotech is Opening the Way to the Bioeconomy

Biology is helping us find more sustainable solutions to the world’s problems. Claus Crone Fuglsang, Senior VP of Research and Technology at Novozymes, gave me an insight into the rapidly moving field of industrial biotech. Novozymes, the world’s largest producer of industrial enzymes, is one of the oldest players in the field of industrial biotech. […]

November 8, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

biotech investment strategies

Interview 31 Oct 2018

Biotech Investment Strategies: How, When and Where to Invest

How, when and where to invest in a biotech company can be essential to the success of both specialized investors and the companies receiving the money. At Refresh Basel, I spoke to Chandra Leo, Partner at the life sciences VC firm HBM Partners, to discuss investment strategies in biotech and his advice for companies seeking […]

October 31, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT

Basel 2018 UG Antibody cover image

Interview 25 Oct 2018

Mastering the Competitive World of Immuno-oncology

In recent years the oncology world has focused on using the immune system to target cancer, with CAR-T cell therapy and other success stories revolutionizing the field. Ulf Grawunder, CEO and founder of NBE Therapeutics, a company using antibody drug conjugates to target cancer, discussed how to navigate the competitive area of immuno-oncology at our […]

October 25, 2018 - 5 minutesmins - By Helen Albert

dinko valerio cover

Interview 23 Oct 2018

Bridging the Academia-Industry Divide: Lessons from a Serial Biotech Entrepreneur

What does it take to be a successful biotech entrepreneur? I put this and other similar questions to Dinko Valerio, a highly experienced Dutch geneticist turned serial entrepreneur and investor. While there are many great scientists, it takes a certain something to be able to cross over into industry and build a profitable business. Dinko […]

October 23, 2018 - 8 minutesmins - By Helen Albert

Hangout acne skin microbiome header 1

Interview 16 Oct 2018

Using the Skin Microbiome to Treat Acne

The microbes living on our skin can play an important role in skin conditions such as acne. Philip talked to Veronika Oudova, CEO and co-founder of the Belgian company S-Biomedic, about how the company plans to fight acne with microbes, and the challenges of launching products in a field that is still unfamiliar to regulators. […]

October 16, 2018 - 4 minutesmins - By Jonathan Smith

Paris Meetup Deinove header 2

Interview 10 Oct 2018

How to Make Industrial Biotech Pay

Making enough money to survive long enough to get a product to market can be tough for any biotech, but even more so for companies operating in the industrial space, where it can be less easy to predict development time and potential financial returns. At our recent Refresh event in Paris, Emmanuel Petiot, CEO of […]

October 10, 2018 - 5 minutesmins - By Helen Albert

failure biotech company

Interview 25 Sep 2018

How to Overcome Failure as a Biotech Company

Turning failure into success is a difficult but much needed skill in a high-risk industry such as biotech. At our latest Labiotech Refresh event, Christine Placet, now the CEO of ophthalmic gene therapy company Horama, shared her personal story of how she saved her previous company, Trophos, from an almost certain failure. The mission of […]

September 25, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Helen Tayton Martin Adaptimmune interview

Interview 11 Sep 2018

How To Break Into The Crowded Immuno-Oncology Space

The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in this crowded field, many companies struggle to make therapies that not only are effective and safe, but that can also be scaled-up, manufactured and commercialized. Helen Tayton-Martin, Chief Business Officer at the biotech company Adaptimmune, shares her advice on how […]

September 11, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT